Enveric Biosciences, Inc.

NasdaqCM ENVB

Enveric Biosciences, Inc. Market Capitalization on February 05, 2025: USD 3.28 M

Enveric Biosciences, Inc. Market Capitalization is USD 3.28 M on February 05, 2025, a 388.70% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Enveric Biosciences, Inc. 52-week high Market Capitalization is USD 8.69 M on January 27, 2025, which is 164.74% above the current Market Capitalization.
  • Enveric Biosciences, Inc. 52-week low Market Capitalization is USD 594.83 K on January 24, 2025, which is -81.88% below the current Market Capitalization.
  • Enveric Biosciences, Inc. average Market Capitalization for the last 52 weeks is USD 3.79 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
SV Wall Street
NasdaqCM: ENVB

Enveric Biosciences, Inc.

CEO Dr. Joseph Edward Tucker Ph.D.
IPO Date May 4, 2015
Location United States
Headquarters 4851 Tamiami Trail North
Employees 7
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Clinical Trials Cosmetics Drugstores & Retail Pharmacies Mental Health Personal Care Tobacco
Description

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

Similar companies

ZURA

Zura Bio Limited

USD 1.78

4.09%

StockViz Staff

February 6, 2025

Any question? Send us an email